Abstract
Brahmi(Bacopa monnieri), an Ayurvedic herb has primarily been used to enhance cognitive ability, memory and learning skills. We present a case study of schizophrenia in which add-on Brahmi extracts 500 mg/day for a period of one month resulted in reduction in psychopathology without any treatment-emergent adverse effect. Although preliminary, our case study suggests therapeutic efficacy of add-on Brahmi in schizophrenia, thus opening up a new dimension of its role in alternative medicines.
Original language | English |
---|---|
Pages (from-to) | 223-225 |
Number of pages | 3 |
Journal | Journal of Ayurveda and Integrative Medicine |
Volume | 3 |
Issue number | 4 |
DOIs | |
Publication status | Published - 01-01-2012 |
All Science Journal Classification (ASJC) codes
- Drug Discovery
- Complementary and alternative medicine